Formic Acid → (1R,5R,6S)-6-[4-(4-Amino-5-oxo-7,8-dihydro-5H-9-oxa-1,3,6-triaza-benzo cyclohepten-6-yl)-phenyl]-tricyclo[3.2.1.0*2,4*]octane-3-carboxylic Acid Methyl Ester
Reaktionsgleichung
[NH2:1][C:2]1[C:7]2[C:8](=[O:20])[N:9]([C:13]3[CH:18]=[CH:17][C:16](I)=[CH:15][CH:14]=3)[CH2:10][CH2:11][O:12][C:6]=2[N:5]=[CH:4][N:3]=1.[CH2:21]([O:23][C:24]([CH:26]([CH2:29][CH2:30][CH:31]=[CH:32][CH3:33])[CH2:27]C)=[O:25])C.N1CCCC[CH2:35]1.C(O)=O>[I-].C([N+](CCCC)(CCCC)CCCC)CCC.CN(C=O)C.C(Cl)(Cl)Cl.CO.CCOC(C)=O>[CH3:21][O:23][C:24]([CH:26]1[CH:27]2[CH:29]1[C@@H:30]1[CH2:31][C@H:32]2[C@@H:33]([C:16]2[CH:17]=[CH:18][C:13]([N:9]3[CH2:10][CH2:11][O:12][C:6]4[N:5]=[CH:4][N:3]=[C:2]([NH2:1])[C:7]=4[C:8]3=[O:20])=[CH:14][CH:15]=2)[CH2:35]1)=[O:25]Komponenten
10
Edukt 4
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 5
Versuchsvorschrift
The named was prepared as follows. A slurry of 4-amino-6-(4-iodophenyl)-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-5(6H)-one (340 mg, 0.89 mmol), tricycle[3.2.1.0*2,4*]oct-6-ene-3-carboxylic acid ethyl ester (240 mg, 1.35 mmol), tetrabutylammonium iodide (67 mg, 0.18 mmol), piperidine (230 mg, 2.7 mmol), formic acid (170 mg, 0.14 mmol) and dichlorobis(acetonitrile) palladium(II) (23 mg, 0.09 mmol) in DMF (0.36 mL) was stirred at 125° C. for 16 hours. The reaction mixture was cooled, diluted into EtOAc, washed with water, saturated aqueous brine, dried over magnesium sulfate and concentrated in vacuo to afford an oil. Chromatography (20 g of silica gel, 1-5% methanol:chloroform) afforded a solid, 127 mg. IC50 78.3 nM.
Aufarbeitung
- customThe named was prepared
- temperatureThe reaction mixture was cooled
- washwashed with water, saturated aqueous brine
- dry with materialdried over magnesium sulfate
- concentrationconcentrated in vacuo
- customto afford an oil
Quellen und Nachweise
- ORD-Eintrag
- ord-4c9057a628154627ba342972ca859969
- Quelldatensatz
- uspto-grants-2010_05
- Patentnummer
- US07718645B2
Notizen zur Reaktion
Wird geladen…